Journal info
Aims and Scope |
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
General Physiology and Biophysics Vol.37, No.5, p.495–514, 2018 |
||
Title: miRNAs as biofluid markers for diagnostics of Alzheimer’s disease: recent status and perspectives | ||
Author: N. Kosikova, M. Cente, V. Cigankova, P. Koson, P. Filipcik | ||
Abstract: After many decades of research in the field of neurodegeneration, we have no effective cure for Alzheimer’s disease (AD), a major form of dementia. It is mainly due to the lack of early, reliable and sensitive biomarkers and incomplete understanding of disease mechanisms at molecular level. Several recently employed biomarkers, especially their combinations, can discriminate advanced stages of AD from other forms of dementia or neuropathy. They do not provide much information on molecular mechanisms of disease, rather they reflect the amount of key histopathological markers in the diseased brain. This review is focussed on novel class of potentially very promising AD biomarkers: extracellular miRNAs in body liquids, such as cerebrospinal fluid and blood. Those have a great potential not only to indicate the presence of AD, but more importantly, to reflect the molecular mechanisms playing a role early at the beginning of the pathogenic pathways consequently leading to AD. We believe this comprehensive review on deregulated miRNAs in AD can be a good source of information for thorough in silico analyses aiming to identify, develop and validate of miRNAs as “diseases mechanism engaged” candidate biomarkers. Having such molecules could bring us closer to the goal – successful treatment of AD. |
||
Keywords: Alzheimer’s disease, miRNA, Biomarker, Diagnostics, Cerebrospinal fluid, Blood | ||
Published online: 02-Oct-2018 | ||
Year: 2018, Volume: 37, Issue: 5 | Page From: 495, Page To: 514 | |
doi:10.4149/gpb_2018019 |
||
|
download file |
|